Cargando…

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

Detalles Bibliográficos
Autores principales:	Goga, Ameena, Bekker, Linda-Gail, Garrett, Nigel, Reddy, Tarylee, Yende-Zuma, Nonhlanhla, Fairall, Lara, Moultrie, Harry, Takalani, Azwidihwi, Trivella, Valentina, Faesen, Mark, Bailey, Veronique, Seocharan, Ishen, Gray, Glenda E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259009/ https://www.ncbi.nlm.nih.gov/pubmed/35809579 http://dx.doi.org/10.1016/S0140-6736(22)01190-4

Ejemplares similares

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
por: Takuva, Simbarashe, et al.
Publicado: (2022)

Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa
por: Gray, Glenda, et al.
Publicado: (2022)

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
por: Jacobson, Barry Frank, et al.
Publicado: (2023)

High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
por: Garrett, Nigel, et al.
Publicado: (2022)

High Asymptomatic Carriage With the Omicron Variant in South Africa
por: Garrett, Nigel, et al.
Publicado: (2022)

Allergic reactions to the Ad26.COV2.S vaccine in South Africa
por: Peter, Jonny, et al.
Publicado: (2021)

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study
por: Bekker, Linda-Gail, et al.
Publicado: (2022)

Joint modelling of longitudinal and time-to-event data: an illustration using CD4 count and mortality in a cohort of patients initiated on antiretroviral therapy
por: Mchunu, Nobuhle N., et al.
Publicado: (2020)

Using joint models to study the association between CD4 count and the risk of death in TB/HIV data
por: Mchunu, Nobuhle N., et al.
Publicado: (2022)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
por: Takuva, Simbarashe, et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
por: Collie, Shirley, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa
por: Tinarwo, Partson, et al.
Publicado: (2019)

A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection
por: Naidoo, Kogieleum, et al.
Publicado: (2018)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa
por: Chibi, Buyisile, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
por: Dawood, Halima, et al.
Publicado: (2018)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves
por: Chandrasingh, Sindhulina, et al.
Publicado: (2023)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Facilitators of professional socialisation of learners in the clinical learning areas: A qualitative systematic review
por: Mafumo, Julia L., et al.
Publicado: (2022)

Decadal epidemiology of malaria in KwaZulu-Natal, a province in South Africa targeting elimination
por: Maharaj, Rajendra, et al.
Publicado: (2019)

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
por: Dorward, Jienchi, et al.
Publicado: (2020)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
por: Naicker, Nivashnee, et al.
Publicado: (2022)

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004
por: Castor, Delivette, et al.
Publicado: (2022)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
por: Hanass-Hancock, Jill, et al.
Publicado: (2021)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kpn03pg1h4mo3p4jldqao2cqhk